Phase I Clinical Results

An example of the pain relieving effects of utilizing StimPad™ in Phase I of our Clinical studies are the graphical examples, below.  For Phase II, the FDA has requested a considerably larger demographic of patients in order to receive clearance for over-the-counter (OTC) use in the United States.

Analyzing the weekly diary of a particular subject, throughout the four week study. Taking the values of the pre use level of pain for all 21 treatments throughout each week; a total of 84 treatments during the study and the values of each post use level of pain for all 21 treatments throughout each week and determined a weekly average PRE and weekly average POST. The graph below indicates PRE (blue) and POST (purple) stimulation results achieved with the use of StimPad™.

In the subjects below, the average level of PRE treatment pain went down each SUCCESSIVE week during the study. As well, the average level of POST treatment pain went down each SUCCESSIVE week during the study. This is indicative...